EcoDrugPlus

Ribosomal Protein L22

Ensembl ID : ENSNGAG00000006068
Gene Symbol: RPL22
3 Cross references
88 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSNGAG00000011140
Gene Symbol: RPL24
3 Cross references
302 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSNGAG00000002075
Gene Symbol: RPL26
2 Cross references
190 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSNGAG00000018509
Gene Symbol: RPL27
2 Cross references
194 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSNGAG00000016459
Gene Symbol: RPL28
2 Cross references
178 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSNGAG00000015276
Gene Symbol: RPL30
2 Cross references
221 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSNGAG00000012132
Gene Symbol: RPL35
2 Cross references
260 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSNGAG00000021002
Gene Symbol: RPL36
2 Cross references
197 Possible Orthologues:

Ribosomal Protein L36a Like

Ensembl ID : ENSNGAG00000021930
Gene Symbol: RPL36AL
2 Cross references
59 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSNGAG00000012401
Gene Symbol: RPL37A
3 Cross references
34 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSNGAG00000014393
Gene Symbol: RPL38
3 Cross references
197 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSNGAG00000005333
Gene Symbol: RPL39
2 Cross references
70 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).